CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
40 hedge funds and large institutions have $2.35M invested in Carisma Therapeutics in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
54% less capital invested
Capital invested by funds: $5.11M → $2.35M (-$2.76M)
Holders
40
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$15K | |
| 2 | +$10.3K | |
| 3 | +$10.1K | |
| 4 |
Goldman Sachs
New York
|
+$8.95K |
| 5 |
LPL Financial
San Diego,
California
|
+$8.75K |
Top Sellers
| 1 | -$551K | |
| 2 | -$34.2K | |
| 3 | -$33.5K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$16.3K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$12.3K |